April 2024 FDA Recall Tramadol Hydrochloride by Rubicon Research Private Limited
D-0487-2024 - Presence of Foreign Tablets

This Class II drug recall was voluntarily initiated by Rubicon Research Private Limited on April 26, 2024 for the product Tramadol Hydrochloride. The FDA reported the reason for recall as presence of foreign tablets. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0487-2024

Reason for Recall
Presence of Foreign Tablets: Pharmacist reported a tablet of baclofen in a bottle of 1000-count tramadol
Initiated
04-26-2024
Reported
05-15-2024
Quantity
2,592 1000-count Bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Rubicon Research Private Limited
Nationwide in the USA
traMADol Hydrochloride Tablets, USP 50 mg, 1000-count bottle, Rx Only, Distributed by: Advagen Pharma Limited, 666 Plainsboro Road Suite 605, Plainsboro, NJ, 08536, USA, Manufactured by: Rubicon Research, Private Limited, Ambernath, Dist. Thane, 421506 India NDC 72888-080-00

Batch or Lot Expiration Information

Lot# : 230774Hl, Exp 4/30/2026